We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

49 hedge funds and large institutions have $3.54M invested in CERo Therapeutics Warrants in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

14% more funds holding

Funds holding: 43 → 49 (+6)

5% less capital invested

Capital invested by funds: $3.72M → $3.54M (-$181K)

Holders
49
Holders Change
+6
Holders Change %
+13.95%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
4
Reduced
2
Closed
8
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$19.7K
2
CCA
Castle Creek Arbitrage
Colorado
+$10.5K
3
WCMNY
Westchester Capital Management (New York)
New York
+$3.94K
4
DCM
Difesa Capital Management
New York
+$3.29K
5
CAC
Cowen and Company
New York
+$3.1K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$17K
2
AGM
Alpine Global Management
New York
-$8K
3
KPF
K2 Principal Fund
Ontario, Canada
-$6K
4
HIM
HGC Investment Management
Ontario, Canada
-$4K
5
BCM
Basso Capital Management
Connecticut
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
26
Cowen and Company
New York
$2.54K +$3.1K +58,905 New
DCM
27
Difesa Capital Management
New York
$2.46K +$3.29K +62,500 New
TCM
28
Tenor Capital Management
New York
$2.15K – – –
BI
29
Bulldog Investors
New Jersey
$2.12K -$45 -857 -2%
KL
30
KIM LLC
Kansas
$2K – – –
SSA
31
Schonfeld Strategic Advisors
New York
$1.55K – – –
SG
32
StoneX Group
New York
$1.29K +$1.58K +30,050 New
Walleye Capital
33
Walleye Capital
New York
$1.12K +$1.36K +25,918 New
WA
34
Whitebox Advisors
Minnesota
$1.08K – – –
Hudson Bay Capital Management
35
Hudson Bay Capital Management
Connecticut
$1.04K – – –
HF
36
HRT Financial
New York
$1K – – –
RCM
37
Rivernorth Capital Management
Florida
$1K – – –
SFM
38
Spartan Fund Management
Canada
$1K – – –
FTUS
39
Flow Traders U.S.
New York
$1K +$303 +5,754 +28%
SRF
40
Silver Rock Financial
California
$996 +$1.22K +23,120 New
GAM
41
Gritstone Asset Management
Maryland
$733 +$895 +17,014 New
CSS
42
Cubist Systematic Strategies
Connecticut
$721 +$881 +16,740 New
Walleye Trading
43
Walleye Trading
New York
$581 +$709 +13,482 New
Calamos Advisors
44
Calamos Advisors
Illinois
$491 – – –
DCM
45
Dupont Capital Management
Delaware
$491 – – –
OMC
46
Old Mission Capital
Illinois
$435 +$531 +10,097 New
RCM
47
Robinson Capital Management
Michigan
$161 – – –
ETH
48
Exos TFP Holdings
New York
$159 +$195 +3,700 New
UBS Group
49
UBS Group
Switzerland
$20 +$26 +496 New
MF
50
Magnetar Financial
Illinois
– -$17K -159,500 Closed
1
2
3

CEROW Hedge Fund Activity: Q4 2022 in Review

49 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2022, worth a combined $3.54M — down 4.9% from $3.72M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CEROW positions and 8 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $19.7K. The largest seller was Magnetar Financial, exiting entirely with an estimated $17K sold.

  • 49 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2022, up from 43 in Q3 2022.
  • Funds reported $3.54M of CERo Therapeutics Warrants stock for Q4 2022, down 4.9% quarter-over-quarter.
  • 14 funds opened new CERo Therapeutics Warrants positions in Q4 2022 and 8 closed out, a net change of +6 holders.
  • The largest CERo Therapeutics Warrants buyer in Q4 2022 was Shaolin Capital Management, an estimated $19.7K added.
  • The largest CERo Therapeutics Warrants seller in Q4 2022 was Magnetar Financial, an estimated $17K sold.

Based on aggregated 13F filings for Q4 2022.